IQVIA_Specifica_White_2024-09-27-1
download-1-Nov-11-2024-04-47-03-6031-PM-1
Press Releases

Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen

SANTA FE, N.M. – 17th March 2023 – Specifica, a Q2 Solutions company focused on innovative in vitro antibody libraries and discovery tools...

March 13, 2023

Press Releases

Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi

SANTA FE, N.M.--(BUSINESS WIRE)--Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under…

June 02, 2022

Press Releases

Specifica is pleased to announce the United States Patent and Trademark Office has granted two patents to Specifica for its innovative Generation 3 Antibody Discovery Platform

SANTA FE, NM – (BUSINESS WIRE) – Mar. 10, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…

March 10, 2022

Press Releases

Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications

SANTA FE, NM – (BUSINESS WIRE) – Jan. 24, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…

January 28, 2022

News

Welcome to AbXtract

A new cloud based software platform specifically designed by scientists working in antibody discovery to rapidly generate antibody leads from next generation sequencing data.

December 02, 2021

Press Releases

OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™

Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – December 2, 2021 – OpenEye Scientific and Specifica, Inc., today announced they are…

December 02, 2021

News

Specifica CTO, Sara D’Angelo, gives a tour of Specifica’s new facilities.

In this brief tour of Specifica’s custom, state of the art laboratories, Sara D’Angelo, Specifica’s CTO, explains the rationale and thinking behind the laboratory design, optimized for all aspects of…

July 21, 2021

News

Specifica CSO, Andrew Bradbury, participates in Covid19 Antibody Roundtable Discussion

In a roundtable discussion, three experts bring perspectives on different methods for generating antibodies, including from naive libraries, patients, and immunizations. They discuss how the COVID-19 pandemic has highlighted the…

April 21, 2021

Press Releases

Specifica Delivers Antibody Platform to UCB to Speed up Development of New Therapeutics

Santa Fe, New Mexico, December 1, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has delivered an exclusive antibody library platform to UCB, a global biopharmaceutical…

December 01, 2020

Press Releases

Specifica Partners With Scholar Rock to Design and Create Antibody Display Library for Therapeutic Biologic Discovery

Santa Fe, New Mexico, August 5, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has designed and created an exclusive antibody display library in collaboration with…

August 05, 2020